Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
2009
Abstract
The comparison of the effects of insulin BIAsp30 and glargine in Type 2 insulin diabetic patients added to glimepiride and metformine. The improvements in HbA1c are considered clinically equivalent to insulin glargine.